5 years ago

Usefulness of Urinary N-Terminal Fragment of Titin to Predict Mortality in Dilated Cardiomyopathy

Titin is associated with myocardial stiffness and hypertrophy, and mutations in its gene have been identified in cardiac myopathies such as dilated cardiomyopathy (DC). It has recently been reported that in damaged muscle, the N-terminal fragment of titin (Titin-N) is cleaved by calpain-3, and urinary Titin-N could be a marker of sarcomere damage. We aimed to investigate the impact of urinary Titin-N on prognosis of DC. We measured urinary levels of Titin-N/creatinine ratio (U-TN/Cr; pmol/mg/dl) in 102 DC patients, and followed up all the patients (mean 1,167 days). The patients were divided into three groups based on the U-TN/Cr: 1st (U-TN/Cr < 3.35, n=34), 2nd (3.35 ≤ U-TN/Cr < 7.26, n=34) and 3rd (7.26 ≤ U-TN/Cr, n=34) tertiles. In the Kaplan-Meier analysis, cardiac and all-cause mortality progressively increased from the 1st to 2nd and 3rd groups (P < 0.05, respectively). In the Cox proportional hazard analyses, U-TN/Cr was a predictor of cardiac and all-cause mortality in DC patients (P < 0.05, respectively). Urinary Titin-N, a novel marker of sarcomere damage, can identify high risk DC patients.

Publisher URL: www.sciencedirect.com/science

DOI: S0002914918301929

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.